Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

D Kellar, S Craft - The Lancet Neurology, 2020 - thelancet.com
Insulin is a peptide secreted by the pancreas and plays an important role in the regulation of
glucose metabolism in peripheral tissues. Although the role of insulin in the periphery is well …

Intranasal insulin for Alzheimer's disease

M Hallschmid - CNS drugs, 2021 - Springer
Brain insulin signaling contributes to memory function and might be a viable target in the
prevention and treatment of memory impairments including Alzheimer's disease. This short …

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial

S Craft, R Raman, TW Chow, MS Rafii, CK Sun… - JAMA …, 2020 - jamanetwork.com
Importance Insulin modulates aspects of brain function relevant to Alzheimer disease and
can be delivered to the brain using intranasal devices. To date, the use of intranasal insulin …

Insulin action in the brain regulates both central and peripheral functions

R Agrawal, CM Reno, S Sharma… - American Journal …, 2021 - journals.physiology.org
The brain has been traditionally thought to be insensitive to insulin, primarily because
insulin does not stimulate glucose uptake/metabolism in the brain (as it does in classic …

[HTML][HTML] The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease

S Shen, Q Liao, YK Wong, X Chen, C Yang… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
In type 2 diabetes mellitus (T2DM) and its related disorders like obesity, the abnormal
protein processing, oxidative stress and proinflammatory cytokines will drive the activation of …

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: A randomized trial

D Kellar, T Register, SN Lockhart, P Aisen, R Raman… - Scientific reports, 2022 - nature.com
Intranasal insulin (INI) has shown promise as a treatment for Alzheimer's disease (AD) in
pilot clinical trials. In a recent phase 2 trial, participants with mild cognitive impairment (MCI) …

Alzheimer's disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN …

RN Martins, V Villemagne, HR Sohrabi… - Journal of …, 2018 - content.iospress.com
Worldwide there are over 46 million people living with dementia, and this number is
expected to double every 20 years reaching about 131 million by 2050. The cost to the …

Brain metabolism alterations in type 2 diabetes: what did we learn from diet-induced diabetes models?

AM Garcia-Serrano, JMN Duarte - Frontiers in neuroscience, 2020 - frontiersin.org
Type 2 diabetes (T2D) is a metabolic disease with impact on brain function through
mechanisms that include glucose toxicity, vascular damage and blood–brain barrier (BBB) …

The link between tau and insulin signaling: implications for Alzheimer's disease and other tauopathies

RA Gonçalves, N Wijesekara, PE Fraser… - Frontiers in cellular …, 2019 - frontiersin.org
The microtubule-associated protein tau (MAPT) is mainly identified as a tubulin binding
protein essential for microtubule dynamics and assembly and for neurite outgrowth …

Metabolic syndrome: Is it time to add the central nervous system?

M Rojas, M Chávez-Castillo, D Pirela, H Parra, M Nava… - Nutrients, 2021 - mdpi.com
Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central
obesity, hyperglycemia, hypertension, and dyslipidemias. The syndrome affects 25% of …